Servier and MaSTherCell SA, a CDMO specializing in the delivery of optimized process industrialization capacities to cell therapy organizations, have signed a master service agreement for the development of a manufacturing platform for allogeneic cell therapies.    Under the agreement, MaSTherCell is developing a CAR-T cell therapy manufacturing platform, which will enable industrial and commercial manufacturing of Servier cell therapy products. This is a critical step in development of these ...